Comparison of Biodentine and MTA Pulpotomies in the Primary Molar Teeth 3 Year Follow up
Launched by ISTANBUL UNIVERSITY · Jan 3, 2018
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • no clinical and radiographic evidence of pulp pathology,
- • no clinical and radiographic symptoms,
- • no history of spontaneous pain and tenderness,
- • no percussion, swelling or sinus tracts and pathologic mobility.
- Exclusion Criteria:
- • any clinical or radiographic evidence of pulp degeneration (spontaneous or nocturnal tooth pain, tenderness to percussion, pathological mobility, internal or external root resorption, swelling or fistula, widened periodontal ligament (PDL)
- • furcal or periapical radiolucency teeth requiring more than 5 minutes to achieve hemostasis during clinical procedure.
- • without permanent successor
About Istanbul University
Istanbul University, a leading institution in Turkey, is dedicated to advancing healthcare through rigorous clinical research and education. Renowned for its commitment to scientific excellence and innovation, the university sponsors clinical trials that aim to enhance medical knowledge and improve patient outcomes. With a diverse team of researchers and healthcare professionals, Istanbul University fosters collaboration across disciplines to explore new therapeutic interventions and contribute to global health advancements. Its robust infrastructure and ethical standards ensure the highest quality in clinical trial management, making it a key player in the field of medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials